4DMedical Ltd's stock soared 5.10% during intraday trading on Friday, following a significant regulatory milestone for the company.
The surge comes after the company announced it received CE Mark certification for its Ct:Vq product, allowing for commercial use in the European Union. This regulatory approval is a key step in expanding the company's market access and potential revenue streams in the European healthcare sector.